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of patients treated by CABG were men (86% for CABG v 80% PTCA, P <
0.001) CABG patients were more likely to have had MI (60% vs PTCA 34%,
P < 0.001), intermittent claudication (16% vs PTCA 6%, P < 0.001). heart
failure (6% vs PTCA 2%), diabetes mellitus (6% vs PTCA 2%) but similar pro-
portion of strokes, smokers, and treated hypertension or hyperlipidaemia.
Pre-procedure both patient groups had similar proportions with; angina (98%
CABG v 93% PTCA). severe angina (grade 3 or4 Candian Cardiovascular Soci-
ety Class, 71 % CABG vs 64% PTCA), and number of antianginal drugs used.
We used the Nottingham Health Profile (NHP) to examine self-perceived well-
being and found pre-procedure scores to be very similar for both groups. De-
spite these similarities CABG patients had higher Brandt scores for severity
of coronary artery disease (p < 0.001) and a higher proportion with impaired
ventricles (p < 0.001).
Conventional 1 year clinical outcomes were: Deaths (all cause 7% CABG
vs 2.5% PTCA, ns), readmissions (31 % CABG vs 38% PTCA), angina (CABG
26% vs PTCA 61 %, P < 0.001), grade 3 + 4 angina (CABG 11 % vs PTCA
53%). Other measures of outcome were; self-perceived effort tolerance> 1
mile (CABG 68% vs PTCA 42%, P < 0.001). antianginal drug use (22% of
CABG patients vs 75% of PTCA, p < 0.001), 1 year self-perceived well-being
scores were greatly improved (p < 0.001 for all dimensions CABG, p < 0.001
for all dimensions PTCA except sleep p < 0.05, and social isolation, p < 0.02).
Scores at 1 year were worse in PTCA than CABG.
Conclusion: Whether cardiac revascularisation is by PTCA or CABG similar
clinical outcome measures including self-perceived well-being are applica-
ble. These may allow the development of outcome targets based not onlyon
conventional morbidity but also on improved patient-perceived well-being.
improvement in matched pts with comparable lesion location, vessel size
(RD). lesion severity IMLD) and acute gain. Multivariate analyses were per-
formed to determine the correlates of minimal lumen at follow-up and lu-
men loss. Matching was considered adequate since lesion distribution, RD
(3.09 vs 3.09 mm) and MLD (1.12 vs 1.12 mm) were equal in both groups.
Stenting lesulted in a larger increase in MLD than DCA (1.41 vs 1.20 mm;
p = 0.0002), similar late loss (0.57 vs 0.66 mm; p = NS) with subsequently
a larger MLD at follow-up (1.96 vs 1.66 mm; p = 0.0001). However, when
additional matching (n = 150 pts) for acute gain (1.34 vs 1.33 mm) was per-
formed,late lumen loss was significantly smaller after stenting 10.52 vs 0.75
mm; p = 0.007) leading to a favorable long-term MLD (1.90 vs 1.66 mm; p =
0.004) when compared with DCA. Multivariate analysis revealed device type,
vessel size and lumen gain as independent predictors for MLD at follow-up.
The changes in MLD are shown in cumulative distribution curves:
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Device CAVEAT·I sites CAVEAT-II sites
pre-CAVEAT post-CAVEAT post-CAVEAT
n % % %
PTCA 539 838 443 685 307 78.1
DCA 69 10.7 91 14.1 39 9.9
Other 35 54 113 175 47 12
• P < 0.0001
There has been a significant decline in the proportion of procedures relying
exclusively on balloon angioplasty and paradoxically, despite the negative
findings of CAVEAT-I. a noteworthy trend towards an increase in use of DCA
and other devices at CAVEAT sites. This paradoxic increase in trend was still
evident when subgroup analysis of American and European CAVEAT-I sites
was performed. These findings suggest that even among investigators in the
trial, there is a lack of influence of CAVEAT-I data on clinical practice patterns.
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Comparative Results of Extraction Atherectomy
(TEC) in Vein Graft Lesions with and without
Thrombus
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Venu Reddy, Cindy L. Grines, Gregory S. Pavlides, Theodore L. Schreiber, Robert
D. Safian. William Beaumont Hospital, Royal Oak, MI
DCA = 1. STENT = a
We compared the results of extraction atherectomy ITEC) in 183 consecutive
vein grafts (SVG) with In = 59,32%) and without thrombus (n = 124,68%)
including clinical data, lesion morphology, immediate angiographic results
and in-hospital complications:
In conclusion, the long-term angiographic outcome of stenting seems
more favorable than of directional atherectomy due to a larger acute lumi-
nal gain and a substantial reduction in late luminal loss. It appears that the
late outcome after an intervention is not only related to extent of luminal
improvement but also to the mechanism of acute gain (device type).
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Influence of Randomized Trials on Clinical
Practice: A Comparison of Directional
Atherectomy and New Device Use Before and
After the CAVEAT Trial at CAVEAT Sites
Nowa Omoigui, Mitchell J. Silver, Lisa Rybicki, Monique Rosenthal, Robert
M. Califf, Eric J. Topol, CAVEAT Investigators. Cleveland Clinic Foundation,
Cleveland, Ohio, Duke University. Durham, North Carolina
In order to evaluate the impact of the Coronary Angioplasty versus Excisional
Atherectomy Trial (CAVEAT-I) on practice patterns of coronary intervention, a
week-long registry of the "universe" of all coronary interventions performed
at 35 investigational sites between April 18 and 22, 1994 was compared with
a similar registry obtained before the trial was initiated. A total of 97% of sites
responded. Additional sites which took part in CAVEAT·II comparing DCA and
PTCA in vein grafts were also audited for generalizability:
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11018-471 A Matched Comparison of the Longterm
Outcome of Directional Coronary Atherectomy
versus Coronary Stenting
Victor Umans, Rein Melkert, Peter de Jaegere, Pim de Feyter, Patrick Serruys.
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Conclusions: For TEC of SVG, the presence of thrombus is associated with
more baseline lesion complexity, reduced clinical success, and increased risk
of no-reflow and clinical complications.
To compare the renarrowing process after atherectomy (DCA) and stenting,
we reviewed the cineangiograms from a prospectively collected series of
234 matched DCA and stent patients (pts) with identical baseline clinical and
angiographic characteristics. In addition, we explored whether the process
of luminal renarrowing was related to the extent or mechanism of luminal
